Send us Feedback

Alexion Pharmaceuticals (ALXN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Income Statement    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Total Revenue 245M 275M 294M 321M 339M
Cost of Revenue 28.3M 31.6M 20.2M 33.1M 29.1M
Gross Profit 216M 243M 274M 287M 310M
Research & Development 45.4M 59.6M 54.3M 63.4M 74.5M
SG&A 87.2M 94.9M 90.0M 113M 109M
Amortization & Deprec 208K 0 0 0 6.37M
Other Expenses 15.9M 5.01M -14.4M 75.9M -541K
Total Operating Expenses 149M 159M 130M 252M 189M
Operating Income 67.8M 83.6M 144M 35.4M 121M
Other Income 58.0K 96.0K -1.38M 72.4M -2.73M
EBIT 67.8M 83.7M 143M 108M 118M
Minority Interest 0 0 0 0 0
Interest Expense 0 1.98M 1.95M 607K 1.17M
Income Before Taxes 67.8M 81.7M 141M 107M 117M
Income Taxes 22.4M 45.5M 48.6M 26.3M 34.5M
Net Income from Continuing Ops 45.4M 36.3M 92.2M 81.0M 82.2M
Income - Discontinued Ops 0 0 0 0 0
Extraordinary Items 0 0 0 0 0
Effect of Accounting Changes 0 0 0 0 0
Other Items 0 0 0 0 0
Net Income 45.4M 36.3M 92.2M 81.0M 82.2M
Preferred Dividends 0 0 0 0 0
Net Income to Common 45.4M 36.3M 92.2M 81.0M 82.2M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki